Definitive Contract 75F40121C00059
- Not listed
- This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for $2,538,816.41 and provides office support services to the FDA's Office of Clinical Policy. The contract is a Delivery Order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and...
- This is a $2,469,135.04 definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, an 8(a) certified Small Disadvantaged Business. The contract is for facilitation and coordination support services for IT initiatives, including regulatory review and production support for the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), support for the Center for Drug Evaluation and Research (CDER),...
- This is a Firm Fixed Price delivery order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business registered to receive federal contract awards since 2014. The objective of this order is to acquire expert consulting support and services to support the mission of the FDA's Office of Business Informatics (OBI). Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB), will provide operational and...
- This is a $4,075,658.29 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business and Economically Disadvantaged Women-Owned Small Business (EDWOSB) certified in the SBA 8(a) program. The contract is for operations and maintenance services for the CDERONE (Center for Drug Evaluation and Research Operations) system, which supports regulatory review and evaluation processes for drugs. Agisol LLC has a history of providing IT services...
- The U.S. Food and Drug Administration (FDA) awarded a $1,189,125.49 time-and-materials contract to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), to streamline processes and enhance new drug review services. This contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions. Agisol LLC specializes in providing IT services and solutions...
- The Food and Drug Administration (FDA) awarded a definitive firm fixed-price contract to Agisol LLC, a small, minority-owned, woman-owned business based in Marriottsville, Maryland, on July 30, 2024, with a ceiling value of $750,814.42. This Competitive 8(a) set-aside contract supports the FDA's personal property management and fleet management programs by delivering analytics, metrics, training, quality assurance, and property management information system (PMIS) services. Work will be...
- This is a labor-hour award made by the U.S. Food and Drug Administration (FDA) to Agisol LLC, an 8(a) certified small disadvantaged business, to provide regulatory review of the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) production support services for the Center for Drug Evaluation and Research (CDER). The contract, valued at $4,499,636.43, runs from the award date of February 4, 2024 through December 17, 2025. Agisol LLC has extensive experience supporting the FDA's...
- The Department of Health and Human Services Food and Drug Administration awarded a $3.8 million definitive contract to Agisol LLC of Silver Spring, Maryland. The contract is for the DOCUMENT ARCHIVING, REPORTING, AND REGULATORY TRACKING SYSTEM and has a period of performance from January 21, 2022 to January 17, 2024. The pricing structure is firm fixed price. The contract was set aside for 8(a) Sole Source small businesses. Agisol LLC will provide document archiving, reporting, and regulatory...
- The Food and Drug Administration (FDA) awarded a delivery order valued at $4.49 million to Agilistek LLC on August 7, 2024, for continued development and support of the Foreign Inspection Planning and Scheduling System (FIPSS). This contract is issued under the 8(a) STARS III Governmentwide Acquisition Contract (GWAC), which is a General Services Administration-managed vehicle designed to support small disadvantaged businesses in providing IT solutions across federal agencies. The award is...
- This is a Task Order awarded by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to Deloitte & Touche LLP, a large professional services firm, under the FDA Safety And Innovation Act Support Services (FDASIA) Blanket Purchase Agreement (BPA). The Task Order, valued at $7,218,610.25, is for analysis and reporting analytics of the FDA's drug safety platform. There is no set-aside designation for this award. Deloitte has subcontracted a portion of the work...
This is a sole source 8(a) contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, a Minority Owned, Economically Disadvantaged, Women-Owned Small Business (EDWOSB) located in the DC Metro area. The contract, valued at $899,910.69, is for business process user support services to the Center for Drug Evaluation and Research (CDER) at the FDA. Agisol LLC has received over $15 million in prime federal contracts from HHS FDA, including work under the 8(a) STARS III GWAC, a $50 billion multiple award contract vehicle for IT services and solutions. The award enables Agisol to provide a range of services to streamline processes, enhance systems functionality, and optimize workflows related to the FDA's new drug reviews, drug safety, and other mission critical activities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 11/10/21 | |
| Not listed | Not listed | $899.9k | 7/8/21 |